Full Schedule

6:15 AM – 7:30 AM ET

5K Run for Cancer Research

7:00 AM – 8:00 AM ET

Non-CE Symposium: Key Considerations for Operationalizing Bispecifics in Relapsed or Refractory Multiple Myeloma

Location: 120-121

*Speaker: – Minnesota Oncology

7:00 AM – 8:00 AM ET

Non-CE Symposium: Essentials for Pharmacists: A Treatment Option for Relapsed or Refractory Multiple Myeloma From Pfizer

Location: 124-125

*Speaker: – USC Norris Comprehensive Cancer Center

7:00 AM – 8:00 AM ET

Non-CE Symposium: Managing Myelofibrosis: A Pharmacist’s Perspective

Location: 122-123

*Speaker: – The Mount Sinai Hospital

7:00 AM – 8:00 AM ET

Special Interest Group (SIG) - Geriatric

Location: 116

7:00 AM – 8:00 AM ET

Special Interest Group (SIG) - New Practitioner

Location: 114

7:00 AM – 8:00 AM ET

Special Interest Group (SIG) - Pediatrics

Location: 117

7:00 AM – 8:00 AM ET

Special Interest Group (SIG) - Precision Health in Oncology

Location: 113

CE: 0

7:00 AM – 8:00 AM ET

Special Interest Group (SIG) - Transplant & Cellular Therapy

Location: 115

8:15 AM – 9:30 AM ET

BC2 - CAR T-Cell Breakthroughs in Lymphoma and Myeloma: Balancing Efficacy and Safety

Location: Ballroom B-C

Speaker: – The University of Texas MD Anderson Cancer Center

CE: 1.25

8:15 AM – 9:30 AM ET

201 - Moving Beyond One Size Fits All for Solid Tumors: Updates in Biomarker Driven Therapies

Location: Ballroom A

Co-Speaker: – Memorial Sloan Kettering Cancer Center

CE: 1.25

9:40 AM – 10:40 AM ET

202-A - To Transplant or Not to Transplant: Current Treatment Approaches for Mantle Cell Lymphoma

Location: Ballroom A

Speaker: – University of Illinois Chicago

CE: .50

9:40 AM – 10:40 AM ET

202-B - Baby Steps: Updates in the Treatment of Infant Leukemia

Location: Ballroom A

Speaker: – Mayo Clinic

CE: .50

9:40 AM – 10:40 AM ET

203-A - Advances in Targeted Therapies for Gastrointestinal Malignancies

Location: Ballroom D

Speaker: – Moffitt Cancer Center

CE: .50

9:40 AM – 10:40 AM ET

203-B - Targeting HER2 Alterations in Patients With Non-Breast/Non-Gastric Cancers

Location: Ballroom D

Speaker: – Memorial Sloan Kettering Cancer Center

CE: .50

9:40 AM – 10:40 AM ET

204-A - Show Me the Money: Optimizing the Electronic Medical Record (EMR) to Improve Biosimilar Utilization and Pharmacy Reimbursement

Location: Ballroom B-C

Speaker: – The University of Kansas Health System

CE: .50

9:40 AM – 10:40 AM ET

204-B - Cannabinoids and the Oncology Patient: Pearls for Pharmacists

Location: Ballroom B-C

Speaker: – Mayo Clinic

CE: .50

10:50 AM – 11:50 AM ET

Member Awards & Business Meeting

Location: Ballroom B-C

*Speaker: – Atrium Health Wake Forest Baptist (WFB)

11:50 AM – 2:15 PM ET

Exhibit Hall and Lunch

Location: Exhibit Hall

12:00 PM – 1:00 PM ET

CE Symposium: Advancements in Early-Stage Breast Cancer: The Role of Oncology Pharmacists in Treatment Optimization

Location: 122-123

Co-Speaker: – Allegheny Health Network

Co-Speaker: – UK HealthCare

Co-Speaker:

CE: 1

12:00 PM – 1:00 PM ET

CE Symposium: Elevating Safety and Adherence in Chronic Myeloid Leukemia Through Oncology Pharmacist Expertise

Location: 120-121

Co-Speaker: – NewYork-Presbyterian Hospital, Columbia University Irving Medical Center

Co-Speaker: – Eshelman School of Pharmacy, University of North Carolina at Chapel Hill

Co-Speaker:

CE: 1

12:00 PM – 1:00 PM ET

CE Symposium: What’s New in NSCLC Therapies? Key Takeaways for Your Pharmacy Practice

Location: 124-125

*Speaker:

CE: 1

12:00 PM – 1:00 PM ET

Leadership Development Roundtable: Career Ladders and Professional Development Plans

Location: 118 - 119

12:00 PM – 1:00 PM ET

Special Interest Group (SIG) - Academia

Location: 114

12:00 PM – 1:00 PM ET

Special Interest Group (SIG) - Administration

Location: 115

12:00 PM – 1:00 PM ET

Special Interest Group (SIG) - Epic (Beacon) Users

Location: 116

12:00 PM – 1:00 PM ET

Special Interest Group (SIG) - Gynecologic Oncology

Location: 117

12:00 PM – 1:00 PM ET

Special Interest Group (SIG) - Specialty Pharmacy

Location: 113

1:00 PM – 2:00 PM ET

Annual Advocacy Update

Location: Ballroom B-C

*Speaker: – HOPA

*Speaker: – The Brooklyn Cancer Center

*Speaker: – CRD Associates

2:15 PM – 3:30 PM ET

205 - Debating the Incorporation of Novel Therapies in Front-Line Acute Lymphoblastic Leukemia Treatment

Location: Ballroom A

Speaker: – University of Utah Huntsman Cancer Institute

Co-Speaker: – University of Utah Huntsman Cancer Institute

CE: 1.25

2:15 PM – 3:30 PM ET

BC3 - The Great Financial Debate: Cost vs Margin for Cancer Care Drugs

Location: Ballroom B-C

Co-Speaker: – Mayo Clinic

CE: 1.25

3:45 PM – 4:45 PM ET

206 - New Practitioner’s Guide to Navigating Your Career

Location: Ballroom A

Co-Speaker: – MD Anderson Cancer Center, Houston, TX

Co-Speaker: – Golisano Children's Hospital

Co-Speaker: – VCU Health System, Richmond VA

Co-Speaker: – UT MD Anderson Cancer Center

CE: 1.0

3:45 PM – 4:45 PM ET

BC4 - Nuances in Neuro-Oncology: Glioma Treatment Advances and New Diagnostic Definitions ("BCOP 101" format)

Location: Ballroom B-C

Speaker: – Huntsman Cancer Institute

CE: 1

3:45 PM – 4:45 PM ET

207 - REACHing for ROCKstars –iNTEGRATing Updates in Chronic Graft Versus Host Disease

Location: Ballroom D

Speaker: – Oregon Health and Sciences University

CE: 1

4:45 PM – 7:30 PM ET

Exhibit Hall Evening Reception

Location: Exhibit Hall

5:00 PM – 6:00 PM ET

Diversity + Belonging Reception

Location: 118 - 119

5:00 PM – 7:30 PM ET

E-Poster Presentations: Completed Research and Trainee Top Ten

Location: Exhibit Hall

5:30 PM – 6:30 PM ET

Non-CE Symposium: Review of Evidence-Based Data for an Antibody-Drug Conjugate in Combination With a PD-1 Inhibitor for 1L la/mUC

Location: 122-123

*Speaker:

5:30 PM – 6:30 PM ET

Non-CE Symposium: EMERALD study update: Exploring the safety and efficacy data in patients with ER+/HER2, ESR1-mutated mBC, including data from subgroup analyses

Location: 120-121

*Speaker: – Menarini Stemline

6:00 PM – 8:00 PM ET

IRC Reception (Invite Only)